검색으로 돌아가기
기록
IDENTIFYING PATIENT RESPONSE TO S1P RECEPTOR MODULATOR ADMINISTRATION
발명심사 중
1조회수
20청구항 · 7 독립항
§ Ⅰ
개요
발명자
Hubert BORELL; Anne GARDIN; Yi JIN; Eric LEGANGNEUX; Mike UFER
IPC 분류
C7D 205/4C12Q 1/6883G1N 33/50G1N 33/569
CPC 분류
C7D205/4C12Q1/6883G1N33/5094G1N33/56972C12Q2600/106C12Q2600/156G1N2800/52
The invention provides a method of assessing the appropriate therapeutic dose of 1-{4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl}-azetidine-3-carboxylic acid to administer to a patient in need thereof, comprising the steps of:
원문 (중국어)
The invention provides a method of assessing the appropriate therapeutic dose of 1-{4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl}-azetidine-3-carboxylic acid to administer to a patient in need thereof, comprising the steps of: